AK132 is an asymmetric bispecific antibody with a "1+1" valency, designed to simultaneously target and block CLDN18.2 and CD47. It features a wild-type IgG1 Fc structure and is currently in the ...

Long An International Port is working with a number of global shipping companies to implement plans to transport goods ...

Archon Biosciences emerges from stealth to advance a new class of biologic invented in Nobel Prize-winning computational ...

Chemistry is more than just beakers and test tubes-it about experimenting discovering and creating reactions that can change the world Whether youre putting together a team for a science project a qui ...